Spyros Bakalis

Consultant Obstetrician

, London

07384... Reveal phone no. >

Spyros Bakalis: Consultant Obstetrician in London

Dr Spyros Bakalis is an accredited Consultant Obstetrician specialising in Fetal Medicine at St Thomas’s Hospital, London. Inspired by his research into the prediction of small babies at the Harris Birthright Research Centre, Mr Bakalis embarked his career into fetal medicine. 

He also practiced high risk obstetrics, with a focus on maternal cardiac diseases and mothers battling with cancer during pregnancy, along with looking after women in labour. 


Book a consultation now07384... Reveal phone no. >

Training and Experience

Dr Bakalis’ completed his postgraduate training before being awarded his MD for his research into the prediction of small babies at the Harris Birthright Research Centre for Fetal Medicine. He was subsequently accredited by the RCOG with his subspecialty in Maternal and Fetal Medicine following his training at University College Hospital London. 

Dr Bakalis was appointed to Guy’s and St Thomas’ Hospital in 2017 with a major role in the fetal medicine unit where he carries out a wide range of diagnostic and therapeutic services, with a special interest in fetuses with growth complications, brain anomalies and placental abnormalities. 

He maintains a strong interest in research and has authored a range of articles and book chapters. He continues to teach both under and postgraduates teaching an array of practical skills whilst also being a director for the ‘Labour Ward Theory Course’. He now serves as college tutor and manages the maternal cardiac clinic along with high risk fetal medicine cases.

Dr Bakalis charges an initial consultation fee of £210.

Treatments

Dr Bakalis was appointed to Guy’s and St Thomas’ Hospital in 2017 with a major role in the fetal medicine unit where he carries out a wide range of diagnostic and therapeutic services, with a special interest in fetuses with growth complications, brain anomalies and placental abnormalities.

Dr Spyros Bakalis also practices high risk obstetrics, with a focus on maternal cardiac diseases and mothers suffering from cancer in pregnancy along with looking after women in labour.

He offers treatments in the following fields for both high and low risk women:

  •  Antenatal Care
  •  Intrapartum Care
  •  Delivery care (Normal Vaginal Delivery and Caesarean section)
  •  Fetal Medicine
  • First Trimester Scan
  • Anomaly Scan
  • Third Trimester (Growth) Scan
  • Twins
  • Amniocentisis
  • Chronic Villous Sampling (CVS)
  •  Maternal cardiac disease and cancer in pregnancy
Book a consultation now07384... Reveal phone no. >

Research interests

Dr Bakalis maintains a strong interest in research and has authored a range of articles and book chapters. He continues to teach both under and postgraduates teaching an array of practical skills whilst also being a director for the 'Labour Ward Theory Course'.

Some of his publications can be seen below:

  • Spina bifida in pregnancy: A review of the evidence for preconception, antenatal, intrapartum and postpartum care. Kenga Sivarajah, Sophie Relph, Radha Sabaratnam, Spyros Bakalis Obstetric Medicine May 2018  
  • A retrospective multicenter study of the natural history of fetal ovarian cysts. Tyraskis A, Bakalis S, Scala C, Syngelaki A, Giuliani S, Davenport M, David AL, Nicolaides K, Eaton S, De Coppi P. J Pediatr Surg. 2018 Feb 12.  
  • A systematic review and meta-analysis on fetal ovarian cysts: impact of size, appearance and prenatal aspiration. Tyraskis A, Bakalis S, David AL, Eaton S, De Coppi P. Prenat Diagn. 2017 Oct;37(10):951-958. Review.  
  • Prediction of small-for-gestational-age neonates: screening by maternal biochemical markers at 30-34 weeks. Bakalis S, Gallo DM, Mendez O, Poon LC, Nicolaides KH. Ultrasound Obstet Gynecol. 2015 Aug;46(2):208-15.  
  • Prediction of small-for-gestational-age neonates: screening by uterine artery Doppler and mean arterial pressure at 30-34 weeks. Bakalis S, Stoilov B, Akolekar R, Poon LC, Nicolaides KH. Ultrasound Obstet Gynecol. 2015 Jun;45(6):707-14.  
  • Prediction of small-for-gestational-age neonates: screening by fetal biometry at 30-34 weeks. Bakalis S, Silva M, Akolekar R, Poon LC, Nicolaides KH. Ultrasound Obstet Gynecol. 2015 May;45(5):551-8.  
  • Outcome of prenatally diagnosed agenesis of the corpus callosum. Fratelli N, Papageorghiou AT, Prefumo F, Bakalis S, Homfray T, Thilaganathan B. Prenat Diagn. 2007 Jun;27(6):512-7.  
  • Outcome of antenatally diagnosed talipes equinovarus in an unselected obstetric population. Bakalis S, Sairam S, Homfray T, Harrington K, Nicolaides K, Thilaganathan B. Ultrasound Obstet Gynecol. 2002 Sep;20(3):226-9.  
  • Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Souka AP, Krampl E, Bakalis S, Heath V, Nicolaides KH. Ultrasound Obstet Gynecol. 2001 Jul;18(1):9-17. Review.  

Book a consultation now07384... Reveal phone no. >

See what patients are saying about Spyros Bakalis

Mr Bakalis’s care during my pregnancy was outstanding. His excellent clinical judgement meant I had complete trust in his decision making and this is combined with a very empathic and kind bedside manner. Being a medic myself I have very high standards for care and Mr Bakalis vastly exceeded my expectations. I cannot recommend him highly enough.

CC

I had my baby in March 2019 and was very happy with the care I received from Mr. Bakalis. I was so lucky to have him scanning me throughout my pregnancy. I cannot recommend him enough: first of all, for his experience as a consultant obstetrician and fetal medicine sonographer, secondly, for his manners and attitude, a genuinely nice person. He managed to scan me every month just to reassure me. I felt in safe hands throughout the nine month we spent together and felt very supported in every decision I had to make regarding me and my baby.

SG

Book an appointment

07384... Reveal phone no. >

info@... Reveal

Languages spoken

  • English
  • Greek

Powered by

LaingBuisson is the chosen provider of independent sector healthcare market data
to the UK Government’s Office for National Statistics.